Meeting
2021 Genitourinary Cancers Symposium
In vitro and in vivo investigations of novel 1,4-napthoquinone sulphomethylene carbohydrate conjugates in prostate cancer.
Authors
Tobias Busenbender
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Tobias Busenbender , Sergey Dyshlovoy , Moritz Kaune , Lukas Boeckelmann , Tobias Lange , Udo Schumacher , Dmitry N Pelageev , Yurii E Sabutskii , Ksenia Borisova , Victor Ph Anufriev , Markus Graefen , Carsten Bokemeyer , Gunhild Von Amsberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 104)
DOI
10.1200/JCO.2021.39.6_suppl.104
Abstract #
104
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Protection of prostate cancer cells from GSK-3β-induced oxidative stress by Il-8 through activating the mTOR signaling pathway.
First Author: Yi Sun
Poster
2016 Genitourinary Cancers Symposium
Pre-clinical rationale for combination PI3K and BRD4 inhibition in advanced prostate cancer.
First Author: Paul Toren
Poster
2014 ASCO Annual Meeting
Effect of combination of proteasome inhibitor marizomib and immunomodulatory agent pomalidomide on synergistic cytotoxicity in multiple myeloma.
First Author: Dharminder Chauhan
Poster
2022 ASCO Genitourinary Cancers Symposium
Interrelation of functional homologous recombination deficiency and hrr pathway alterations in prostate cancer.
First Author: Jason Zhu